115 related articles for article (PubMed ID: 23250737)
1. Low-risk thyroid cancer, surgical training, and radioactive iodine.
Shaha AR
Ann Surg Oncol; 2013 Mar; 20(3):703-4. PubMed ID: 23250737
[No Abstract] [Full Text] [Related]
2. Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.
Schuessler KM; Banerjee M; Yang D; Stewart AK; Doherty GM; Haymart MR
Ann Surg Oncol; 2013 Mar; 20(3):733-8. PubMed ID: 23224826
[TBL] [Abstract][Full Text] [Related]
3. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
Roman BR; Feingold JH; Patel SG; Shaha AR; Shah JP; Tuttle RM; Epstein AJ
Thyroid; 2014 Oct; 24(10):1549-50. PubMed ID: 25065817
[No Abstract] [Full Text] [Related]
4. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.
Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ
Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer: an overview.
Haq M; Harmer C
Nucl Med Commun; 2004 Sep; 25(9):861-7. PubMed ID: 15319589
[No Abstract] [Full Text] [Related]
6. Use of radioactive iodine for thyroid cancer.
Haymart MR; Banerjee M; Stewart AK; Koenig RJ; Birkmeyer JD; Griggs JJ
JAMA; 2011 Aug; 306(7):721-8. PubMed ID: 21846853
[TBL] [Abstract][Full Text] [Related]
7. Factors that influence radioactive iodine use for thyroid cancer.
Papaleontiou M; Banerjee M; Yang D; Sisson JC; Koenig RJ; Haymart MR
Thyroid; 2013 Feb; 23(2):219-24. PubMed ID: 23134514
[TBL] [Abstract][Full Text] [Related]
8. Current issues in the management of differentiated thyroid cancer.
Mallick UK; Charalambous H
Nucl Med Commun; 2004 Sep; 25(9):873-81. PubMed ID: 15319591
[No Abstract] [Full Text] [Related]
9. Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's role.
Luster M; Musholt TJ
Nat Rev Endocrinol; 2013 Mar; 9(3):140-1. PubMed ID: 23183674
[No Abstract] [Full Text] [Related]
10. Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection.
Deutschmann MW; Chin-Lenn L; Nakoneshny SC; Dort JC; Pasieka JL; Chandarana SP
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):55. PubMed ID: 27793192
[TBL] [Abstract][Full Text] [Related]
11. Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.
Goffredo P; Thomas SM; Dinan MA; Perkins JM; Roman SA; Sosa JA
JAMA Intern Med; 2015 Apr; 175(4):638-40. PubMed ID: 25686394
[No Abstract] [Full Text] [Related]
12. The British Thyroid Association guidelines for the management of thyroid cancer in adults.
Watkinson JC;
Nucl Med Commun; 2004 Sep; 25(9):897-900. PubMed ID: 15319594
[No Abstract] [Full Text] [Related]
13. Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study.
Sawka AM; Straus S; Gafni A; Meiyappan S; David D; Rodin G; Brierley JD; Tsang RW; Thabane L; Rotstein L; Ezzat S; Goldstein DP
Support Care Cancer; 2012 Mar; 20(3):641-5. PubMed ID: 22072050
[TBL] [Abstract][Full Text] [Related]
14. Consensus conference on well-differentiated thyroid cancer: a summary.
Pasieka JL; Rotstein LE
Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.
Sawka AM; Rotstein L; Brierley JD; Tsang RW; Thabane L; Gafni A; Straus S; Kamalanathan S; Zhao B; Goldstein DP; Rambaldini G; Ezzat S
Thyroid; 2007 Dec; 17(12):1235-42. PubMed ID: 17988197
[TBL] [Abstract][Full Text] [Related]
16. Do Lower-Risk Thyroid Cancer Patients Who Live in Regions with More Aggressive Treatments Have Better Outcomes?
Hall SF; Irish J; Groome P; Griffiths R; Hurlbut D
Thyroid; 2017 Oct; 27(10):1246-1257. PubMed ID: 28851261
[TBL] [Abstract][Full Text] [Related]
17. The role of radiotherapy and radioactive iodine in the treatment of thyroid cancer without metastases.
Tubiana M; Charbord P; Cukersztein W; Sarrazin D; Fontaine F; Parmentier C
Ann Radiol (Paris); 1977; 20(8):801-9. PubMed ID: 610552
[No Abstract] [Full Text] [Related]
18. Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
Rosario PW
Eur J Endocrinol; 2013 Nov; 169(5):L1. PubMed ID: 24084443
[No Abstract] [Full Text] [Related]
19. Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
Pacini F
Eur J Endocrinol; 2013 Nov; 169(5):L2. PubMed ID: 24084444
[No Abstract] [Full Text] [Related]
20. Radioactive iodine therapy for malignant and benign thyroid disease: a Canadian national survey of physician practice.
Demeter S; Leslie WD; Levin DP
Nucl Med Commun; 2005 Jul; 26(7):613-21. PubMed ID: 15942482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
